Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alphanosos SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11100
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alphanosos SAS (Alphanosos) is a developer of novel therapies for the treatment of chronic inflammatory diseases. The company offers pure antibiofilms and antibiotics. It concentrates on bacterial biofilms in various therapeutic areas such as dermatological, bucco-dental and respiratory diseases. Alphanosos develops compounds from plants or bacterial extracts using proprietary assays, and artificial intelligence software. The company’s screening data analysis algorithms and software allow discoveries of new classes of complex and synergistic plant mixes that dismantle bacterial communities relevant to the targeted chronic and acute diseases. It works in partnership with other organizations for the co-development of solutions in the fields of colorectal and stomach cancer; co-drugs to enhance or restore efficacy of existing antibiotics. The company operates in France and the US. Alphanosos is headquartered in Riom, France.

Alphanosos SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alphanosos SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alphanosos SAS, Medical Devices Deals, 2012 to YTD 2018 9
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alphanosos SAS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alphanosos Enters into Agreement with Southern European Dermato-Cosmetic Company 11
Alphanosos Forms Joint Venture with American University 12
Alphanosos Enters into Research Agreement with LIttoral ENvironnement et Societes and American University 13
Alphanosos SAS – Key Competitors 14
Alphanosos SAS – Key Employees 15
Alphanosos SAS – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Alphanosos SAS, Pharmaceuticals & Healthcare, Key Facts 2
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alphanosos SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alphanosos SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Alphanosos SAS, Medical Devices Deals, 2012 to YTD 2018 9
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alphanosos Enters into Agreement with Southern European Dermato-Cosmetic Company 11
Alphanosos Forms Joint Venture with American University 12
Alphanosos Enters into Research Agreement with LIttoral ENvironnement et Societes and American University 13
Alphanosos SAS, Key Competitors 14
Alphanosos SAS, Key Employees 15
Alphanosos SAS, Subsidiaries 16

List of Figures
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alphanosos SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alphanosos SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Young & Co.’s Brewery plc (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Patrys Ltd (PAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC1 an immunoglobulin M (IgM) type antibody used for the treatment of gastric cancer; PAT-SM6 is a full …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Green Cross Cell Corp (031390):企業の財務・戦略的SWOT分析
    Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Carlisle Companies Inc:企業の戦略・SWOT・財務情報
    Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tsumura & co (4540):製薬・医療:M&Aディール及び事業提携情報
    Summary Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • The Hub Power Co Ltd:発電所・企業SWOT分析
    The Hub Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Avacta Group Plc (AVCT)-医療機器分野:企業M&A・提携分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • Kia Motors Corporation:企業の戦略・SWOT・財務分析
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Amey Plc:企業の戦略的SWOT分析
    Amey Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Adler Solar Services GmbH:電力:M&Aディール及び事業提携情報
    Summary ADLER Solar Services GmbH (ADLER Solar), formerly ADLER Personal Services GmbH, is a renewable energy company which provides technical solutions and services for solar photovoltaic (PV) industry. The company's service offerings include engineering, procurement and construction management; in …
  • ScinoPharm Taiwan Ltd (1789):企業の財務・戦略的SWOT分析
    ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oilex Ltd (OEX):企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Berthold Technologies GmbH & Co. KG:企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Datang International Power Generation Co Ltd (991)-エネルギー分野:企業M&A・提携分析
    Summary Datang International Power Generation Company Limited (Datang Power), a subsidiary of China Datang Corporation, is an independent power generation company. It develops power plants; produces and distributes electricity; and sells heat. The company generates electricity from coal-fired genera …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆